Review



human scf elisa kit  (Elabscience Biotechnology)


Bioz Verified Symbol Elabscience Biotechnology is a verified supplier
Bioz Manufacturer Symbol Elabscience Biotechnology manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Elabscience Biotechnology human scf elisa kit
    HCC cells promote MC migration and sustain MC proliferation. (A, B) Timer3.0 database analysis of <t>SCF</t> expression in tumors and correlation analysis between SCF and MCs; (C) <t>ELISA</t> detection of SCF levels in tumor tissues and adjacent tissues; (D) Correlation analysis between TAMC density and SCF concentration in HCC tumor tissues; (E): Flow cytometry identification of expanded hMCs at week 4; (F, G) Transwell assay for hMC migration capacity; (H, I) Flow cytometry for hMC proliferation; (J, K) Flow cytometry for hMC cell cycle. Data are presented as mean ± SD. Figure (B) used independent samples t ‐tests ( n = 59). (D) Spearman 's rank correlation analysis ( n = 59); (G/I/K), one‐way ANOVA with Tukey's post‐hoc multiple comparison test ( N = 3). * indicates p < 0.05; *** indicates p < 0.001.
    Human Scf Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/scf+elisa+kit/Human+SCF+(Stem+Cell+Factor)+ELISA+Kit/pmc13682500-84-5-10
    Average 92 stars, based on 3 article reviews
    human scf elisa kit - by Bioz Stars, 2026-11
    92/100 stars

    Images

    1) Product Images from "Tumor‐Associated Mast Cells Drive Immunosuppression and Resistance to Anti‐PD‐1 Therapy in Hepatocellular Carcinoma Through CCL17/CCR4‐mediated Regulatory T‐Cell Recruitment"

    Article Title: Tumor‐Associated Mast Cells Drive Immunosuppression and Resistance to Anti‐PD‐1 Therapy in Hepatocellular Carcinoma Through CCL17/CCR4‐mediated Regulatory T‐Cell Recruitment

    Journal: Journal of Biochemical and Molecular Toxicology

    doi: 10.1002/jbt.71127

    HCC cells promote MC migration and sustain MC proliferation. (A, B) Timer3.0 database analysis of SCF expression in tumors and correlation analysis between SCF and MCs; (C) ELISA detection of SCF levels in tumor tissues and adjacent tissues; (D) Correlation analysis between TAMC density and SCF concentration in HCC tumor tissues; (E): Flow cytometry identification of expanded hMCs at week 4; (F, G) Transwell assay for hMC migration capacity; (H, I) Flow cytometry for hMC proliferation; (J, K) Flow cytometry for hMC cell cycle. Data are presented as mean ± SD. Figure (B) used independent samples t ‐tests ( n = 59). (D) Spearman 's rank correlation analysis ( n = 59); (G/I/K), one‐way ANOVA with Tukey's post‐hoc multiple comparison test ( N = 3). * indicates p < 0.05; *** indicates p < 0.001.
    Figure Legend Snippet: HCC cells promote MC migration and sustain MC proliferation. (A, B) Timer3.0 database analysis of SCF expression in tumors and correlation analysis between SCF and MCs; (C) ELISA detection of SCF levels in tumor tissues and adjacent tissues; (D) Correlation analysis between TAMC density and SCF concentration in HCC tumor tissues; (E): Flow cytometry identification of expanded hMCs at week 4; (F, G) Transwell assay for hMC migration capacity; (H, I) Flow cytometry for hMC proliferation; (J, K) Flow cytometry for hMC cell cycle. Data are presented as mean ± SD. Figure (B) used independent samples t ‐tests ( n = 59). (D) Spearman 's rank correlation analysis ( n = 59); (G/I/K), one‐way ANOVA with Tukey's post‐hoc multiple comparison test ( N = 3). * indicates p < 0.05; *** indicates p < 0.001.

    Techniques Used: Migration, Analysis, Expressing, Enzyme-linked Immunosorbent Assay, Concentration Assay, Flow Cytometry, Transwell Assay, Comparison, X-Ray Photoelectron Spectroscopy

    TAMCs recruit Tregs into the tumor microenvironment by secreting chemokines. (A) ELISA detection of CCL1, CCL5, CCL17, CCL22, and CCL28 secretion by TAMCs (after subtracting CCL1, CCL5, CCL17, CCL22, and CCL28 levels in TCCS); (B) ELISA detection of CCL17 levels in tumor tissues and adjacent tissues; (C) Correlation analysis between TAMCs and CCL17 concentration; D: Correlation analysis between Tregs and CCL17 concentration; (E, F) Transwell migration assay to assess Treg migration capacity. Data are presented as mean ± SD. (A, B), independent samples t ‐tests ( N = 3); (C, D) Spearman 's rank correlation analysis ( n = 59); (F), one‐way ANOVA and Tukey's multiple comparison test ( N = 3). * indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001.
    Figure Legend Snippet: TAMCs recruit Tregs into the tumor microenvironment by secreting chemokines. (A) ELISA detection of CCL1, CCL5, CCL17, CCL22, and CCL28 secretion by TAMCs (after subtracting CCL1, CCL5, CCL17, CCL22, and CCL28 levels in TCCS); (B) ELISA detection of CCL17 levels in tumor tissues and adjacent tissues; (C) Correlation analysis between TAMCs and CCL17 concentration; D: Correlation analysis between Tregs and CCL17 concentration; (E, F) Transwell migration assay to assess Treg migration capacity. Data are presented as mean ± SD. (A, B), independent samples t ‐tests ( N = 3); (C, D) Spearman 's rank correlation analysis ( n = 59); (F), one‐way ANOVA and Tukey's multiple comparison test ( N = 3). * indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001.

    Techniques Used: Enzyme-linked Immunosorbent Assay, Analysis, Concentration Assay, Transwell Migration Assay, Migration, Comparison

    The TAMCs‐Tregs axis inhibits CD8 + T cell function. (A, B) Flow cytometry analysis of Treg‐mediated suppression of CD8 + T cell proliferation; (C–F) ELISA for Granzyme B, IFN‐γ, TNF‐α, and Perforin in supernatants from CD8 + T cell proliferation assays. Data are presented as mean ± SD. One‐way ANOVA was performed, followed by Tukey's multiple comparison test for post‐hoc analysis ( N = 3). * indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001.
    Figure Legend Snippet: The TAMCs‐Tregs axis inhibits CD8 + T cell function. (A, B) Flow cytometry analysis of Treg‐mediated suppression of CD8 + T cell proliferation; (C–F) ELISA for Granzyme B, IFN‐γ, TNF‐α, and Perforin in supernatants from CD8 + T cell proliferation assays. Data are presented as mean ± SD. One‐way ANOVA was performed, followed by Tukey's multiple comparison test for post‐hoc analysis ( N = 3). * indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001.

    Techniques Used: Cell Function Assay, Flow Cytometry, Analysis, Enzyme-linked Immunosorbent Assay, Comparison

    Combination therapy of anti‐PD‐1 antibody and CCR4 antagonists reshapes the tumor immune microenvironment in HCC. (A–F) Flow cytometry analysis of immune cell proportions (MCs, Tregs, CD8 + T cells) in tumor tissue; G–K: ELISA detection of Granzyme B, IFN‐γ, TNF‐α, Perforin, and CCL17 levels. Data are presented as mean ± SD. One‐way ANOVA was performed, followed by Tukey's multiple comparison test for post‐hoc analysis ( n = 6). * indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001.
    Figure Legend Snippet: Combination therapy of anti‐PD‐1 antibody and CCR4 antagonists reshapes the tumor immune microenvironment in HCC. (A–F) Flow cytometry analysis of immune cell proportions (MCs, Tregs, CD8 + T cells) in tumor tissue; G–K: ELISA detection of Granzyme B, IFN‐γ, TNF‐α, Perforin, and CCL17 levels. Data are presented as mean ± SD. One‐way ANOVA was performed, followed by Tukey's multiple comparison test for post‐hoc analysis ( n = 6). * indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001.

    Techniques Used: Flow Cytometry, Analysis, Immune Cell, Tissue, Enzyme-linked Immunosorbent Assay, Comparison

    Validation of the synergistic antitumor efficacy of the triple‐drug therapy in an in situ Hepa1‐6 HCC model. (A) Representative images of in situ tumors; (B): Tumor volume in each group; (C) Tumor weight in each group; (D) Average ratio of liver weight to body weight; (E, F): Ki67 immunohistochemical staining and quantitative analysis; (G–L) Flow cytometry detection of the proportions of various immune cells (mast cells, Tregs, CD8 + T cells); (M) ELISA detection of Granzyme B, IFN‐γ, TNF‐α, and perforin levels. Data are presented as mean ± SD. One‐way ANOVA was performed, followed by Tukey's multiple comparison test for post‐hoc analysis ( n = 6).
    Figure Legend Snippet: Validation of the synergistic antitumor efficacy of the triple‐drug therapy in an in situ Hepa1‐6 HCC model. (A) Representative images of in situ tumors; (B): Tumor volume in each group; (C) Tumor weight in each group; (D) Average ratio of liver weight to body weight; (E, F): Ki67 immunohistochemical staining and quantitative analysis; (G–L) Flow cytometry detection of the proportions of various immune cells (mast cells, Tregs, CD8 + T cells); (M) ELISA detection of Granzyme B, IFN‐γ, TNF‐α, and perforin levels. Data are presented as mean ± SD. One‐way ANOVA was performed, followed by Tukey's multiple comparison test for post‐hoc analysis ( n = 6).

    Techniques Used: Biomarker Discovery, In Situ, Immunohistochemical staining, Staining, Analysis, Flow Cytometry, Enzyme-linked Immunosorbent Assay, Comparison

    Related Articles

    Enzyme-linked Immunosorbent Assay:

    Article Title: Molecular Hydrogen Protects Human Melanocytes from Oxidative Stress by Activating Nrf2 Signaling.
    Article Snippet: Cellular ATP levels (JianCheng Bioengineering Institute, NanJing, Jiangsu, China) were assayed according to the manufacturer’s instructions. .. Human CXCL9, CXCL10, and CXCL16 Quantikine ELISA kits (R&D Systems, Minneapolis, MN) and an SCF ELISA kit (Elabscience Biotechnology, Wuhan, China) were used to analyze cell supernatant samples according to the manufacturer’s instructions. .. Determination of cell viability by CCK8 assay Cell viability was measured using the CCK8 assay (Cell Counting Kit-8; Beyotime Biotechnology, Shanghai, China) following the manufacturer’s instructions.



    Similar Products

    92
    Elabscience Biotechnology human scf elisa kit
    HCC cells promote MC migration and sustain MC proliferation. (A, B) Timer3.0 database analysis of <t>SCF</t> expression in tumors and correlation analysis between SCF and MCs; (C) <t>ELISA</t> detection of SCF levels in tumor tissues and adjacent tissues; (D) Correlation analysis between TAMC density and SCF concentration in HCC tumor tissues; (E): Flow cytometry identification of expanded hMCs at week 4; (F, G) Transwell assay for hMC migration capacity; (H, I) Flow cytometry for hMC proliferation; (J, K) Flow cytometry for hMC cell cycle. Data are presented as mean ± SD. Figure (B) used independent samples t ‐tests ( n = 59). (D) Spearman 's rank correlation analysis ( n = 59); (G/I/K), one‐way ANOVA with Tukey's post‐hoc multiple comparison test ( N = 3). * indicates p < 0.05; *** indicates p < 0.001.
    Human Scf Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/scf+elisa+kit/Human+SCF+(Stem+Cell+Factor)+ELISA+Kit/pmc13682500-84-5-10
    Average 92 stars, based on 1 article reviews
    human scf elisa kit - by Bioz Stars, 2026-11
    92/100 stars
      Buy from Supplier

    93
    Kingfisher Biotech elisa kit
    HCC cells promote MC migration and sustain MC proliferation. (A, B) Timer3.0 database analysis of <t>SCF</t> expression in tumors and correlation analysis between SCF and MCs; (C) <t>ELISA</t> detection of SCF levels in tumor tissues and adjacent tissues; (D) Correlation analysis between TAMC density and SCF concentration in HCC tumor tissues; (E): Flow cytometry identification of expanded hMCs at week 4; (F, G) Transwell assay for hMC migration capacity; (H, I) Flow cytometry for hMC proliferation; (J, K) Flow cytometry for hMC cell cycle. Data are presented as mean ± SD. Figure (B) used independent samples t ‐tests ( n = 59). (D) Spearman 's rank correlation analysis ( n = 59); (G/I/K), one‐way ANOVA with Tukey's post‐hoc multiple comparison test ( N = 3). * indicates p < 0.05; *** indicates p < 0.001.
    Elisa Kit, supplied by Kingfisher Biotech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/scf+elisa+kit/Swine+SCF+Do-It-Yourself+ELISA/pm41156603-78-27-29
    Average 93 stars, based on 1 article reviews
    elisa kit - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    RayBiotech inc rabbit elisa kits
    HCC cells promote MC migration and sustain MC proliferation. (A, B) Timer3.0 database analysis of <t>SCF</t> expression in tumors and correlation analysis between SCF and MCs; (C) <t>ELISA</t> detection of SCF levels in tumor tissues and adjacent tissues; (D) Correlation analysis between TAMC density and SCF concentration in HCC tumor tissues; (E): Flow cytometry identification of expanded hMCs at week 4; (F, G) Transwell assay for hMC migration capacity; (H, I) Flow cytometry for hMC proliferation; (J, K) Flow cytometry for hMC cell cycle. Data are presented as mean ± SD. Figure (B) used independent samples t ‐tests ( n = 59). (D) Spearman 's rank correlation analysis ( n = 59); (G/I/K), one‐way ANOVA with Tukey's post‐hoc multiple comparison test ( N = 3). * indicates p < 0.05; *** indicates p < 0.001.
    Rabbit Elisa Kits, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/scf+elisa+kit/Custom+Rabbit+SCF+ELISA/pmc12166800__mmc1-29-6-10
    Average 93 stars, based on 1 article reviews
    rabbit elisa kits - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    R&D Systems mouse scf quantikine elisa kit
    Mesenchymal KITL loss within PSCs accompanies pancreatic tumorigenesis. A, Uniform manifold approximation and projection (UMAP) visualization of expression of the indicated genes in normal PSCs and PSC-derived CAFs from scRNA-seq data ( n = 2 replicates pooled from n = 5 mice per arm). B, UMAP visualization of Il6 , Il33 , Col1a1 , and Col1a2 gene expression from normal PSCs and PSC-derived CAFs scRNA-seq dataset ( n = 2 replicates pooled from n = 5 mice per arm). C, UMAP visualization of Kitl transcript expression in normal PSCs and PSC-derived CAFs scRNA-seq dataset ( n = 2 replicates pooled from n = 5 mice per arm). D, Left, UMAP illustrating the cellular landscape of normal pancreatic (blue) and PDAC (red) mesenchymal cells, comprising 5,337 normal and 2,861 tumor cells. Harmony was used to integrate the datasets and correct for batch effects. Right, Monocle 3 trajectory analysis was used to depict expression of the Kitl gene along the inferred pseudotime trajectory. Cells are colored based on Kitl expression levels, with values ranging from low (black) to high (yellow), revealing the spatial and temporal expression patterns of Kitl ( n = 2 replicates pooled from n = 5 mice per arm). E, Left, qRT-PCR analysis of Kitl in quiescent (day 0) and culture-activated (day 7, on plastic) primary PSCs. Right, <t>Quantikine</t> <t>ELISA</t> KITL measurement of supernatant collected from primary PSCs in preactivated (day 2) and activated (day 10) states after 48 hours of incubation with media change on day 8 to harvest for day 10 sample. Immortalized ImPSC-1 included as the reference point. Data represents biological triplicate. F, qRT-PCR analysis of Kitl and Pdgfr α in indicated cell populations. Data show representative technical triplicates. G, Representative brightfield images of primary human PSCs and other mesenchyme. Scale bar, 50 μm. H, qRT-PCR analysis of indicated genes in primary human PSCs and other mesenchyme, shown for three independent patient samples. I, qRT-PCR analysis of Kitl in quiescent (day 0) and conditioned media–activated (day 14) primary human PSCs. Data represent biological triplicate. J, Representative images (left) and quantification (right) of RNA FISH staining for Fabp4 (green) and Kitl (red) in murine normal pancreas ( n = 3). Scale bar, 10 μm. Below, Representative RNAscope staining of GFP (green) protein and Kitl (red) mRNA in PDAC from the genetically engineered mouse model (GEMM) depicted in ( n = 3). Scale bar, 10 μm. K, Representative images and quantification of RNA FISH staining for VIM (green) and KITL (red) in human PDAC tissues between benign adjacent and PDAC regions ( n = 3). Scale bar, 20 μm. L, Representative images and quantification of RNAscope staining for Kitl (red) mRNA expression, GFP (green), and CD31 (magenta) in murine normal pancreas from Rosa26 mTmG/+ ;Fabp4-Cre mice ( n = 3). Scale bar, 20 μm. M, Representative images and quantification of RNAscope staining for GFP (green) protein and Kitl (red) mRNA in GEMM low-grade PanIN ( n = 3). Scale bar, 20 μm. N, Representative image of IHC staining for phospho-c-Kit (Y721, red) in normal murine pancreas ( n = 3). Scale bar, 10 μm. O, Representative images of IHC staining for vimentin (VIM, green) and Phospho-c-Kit (Y703, red) in benign adjacent and human PDAC tissues ( n = 3) Scale bar, 10 μm. For image quantification, at least four fields per tissue were analyzed and averaged. An unpaired t test was performed for comparisons between two groups. For comparisons more than two groups, significance was determined by the ordinary one-way ANOVA. Data are represented as mean ± SEM;*, P < 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001; Benign Adj., benign adjacent; CM, conditioned media; ns, not significant; other mes., other mesenchyme.
    Mouse Scf Quantikine Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/scf+elisa+kit/Mouse+SCF+Quantikine+ELISA+Kit/pmc12046321-346-24-29
    Average 93 stars, based on 1 article reviews
    mouse scf quantikine elisa kit - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    94
    Proteintech mouse kitlg elisa kit
    Mesenchymal KITL loss within PSCs accompanies pancreatic tumorigenesis. A, Uniform manifold approximation and projection (UMAP) visualization of expression of the indicated genes in normal PSCs and PSC-derived CAFs from scRNA-seq data ( n = 2 replicates pooled from n = 5 mice per arm). B, UMAP visualization of Il6 , Il33 , Col1a1 , and Col1a2 gene expression from normal PSCs and PSC-derived CAFs scRNA-seq dataset ( n = 2 replicates pooled from n = 5 mice per arm). C, UMAP visualization of Kitl transcript expression in normal PSCs and PSC-derived CAFs scRNA-seq dataset ( n = 2 replicates pooled from n = 5 mice per arm). D, Left, UMAP illustrating the cellular landscape of normal pancreatic (blue) and PDAC (red) mesenchymal cells, comprising 5,337 normal and 2,861 tumor cells. Harmony was used to integrate the datasets and correct for batch effects. Right, Monocle 3 trajectory analysis was used to depict expression of the Kitl gene along the inferred pseudotime trajectory. Cells are colored based on Kitl expression levels, with values ranging from low (black) to high (yellow), revealing the spatial and temporal expression patterns of Kitl ( n = 2 replicates pooled from n = 5 mice per arm). E, Left, qRT-PCR analysis of Kitl in quiescent (day 0) and culture-activated (day 7, on plastic) primary PSCs. Right, <t>Quantikine</t> <t>ELISA</t> KITL measurement of supernatant collected from primary PSCs in preactivated (day 2) and activated (day 10) states after 48 hours of incubation with media change on day 8 to harvest for day 10 sample. Immortalized ImPSC-1 included as the reference point. Data represents biological triplicate. F, qRT-PCR analysis of Kitl and Pdgfr α in indicated cell populations. Data show representative technical triplicates. G, Representative brightfield images of primary human PSCs and other mesenchyme. Scale bar, 50 μm. H, qRT-PCR analysis of indicated genes in primary human PSCs and other mesenchyme, shown for three independent patient samples. I, qRT-PCR analysis of Kitl in quiescent (day 0) and conditioned media–activated (day 14) primary human PSCs. Data represent biological triplicate. J, Representative images (left) and quantification (right) of RNA FISH staining for Fabp4 (green) and Kitl (red) in murine normal pancreas ( n = 3). Scale bar, 10 μm. Below, Representative RNAscope staining of GFP (green) protein and Kitl (red) mRNA in PDAC from the genetically engineered mouse model (GEMM) depicted in ( n = 3). Scale bar, 10 μm. K, Representative images and quantification of RNA FISH staining for VIM (green) and KITL (red) in human PDAC tissues between benign adjacent and PDAC regions ( n = 3). Scale bar, 20 μm. L, Representative images and quantification of RNAscope staining for Kitl (red) mRNA expression, GFP (green), and CD31 (magenta) in murine normal pancreas from Rosa26 mTmG/+ ;Fabp4-Cre mice ( n = 3). Scale bar, 20 μm. M, Representative images and quantification of RNAscope staining for GFP (green) protein and Kitl (red) mRNA in GEMM low-grade PanIN ( n = 3). Scale bar, 20 μm. N, Representative image of IHC staining for phospho-c-Kit (Y721, red) in normal murine pancreas ( n = 3). Scale bar, 10 μm. O, Representative images of IHC staining for vimentin (VIM, green) and Phospho-c-Kit (Y703, red) in benign adjacent and human PDAC tissues ( n = 3) Scale bar, 10 μm. For image quantification, at least four fields per tissue were analyzed and averaged. An unpaired t test was performed for comparisons between two groups. For comparisons more than two groups, significance was determined by the ordinary one-way ANOVA. Data are represented as mean ± SEM;*, P < 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001; Benign Adj., benign adjacent; CM, conditioned media; ns, not significant; other mes., other mesenchyme.
    Mouse Kitlg Elisa Kit, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/scf+elisa+kit/Mouse+SCF+ELISA+Kit/pm40250508-126-16-20
    Average 94 stars, based on 1 article reviews
    mouse kitlg elisa kit - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    93
    R&D Systems mouse scf quantifikine elisa kit
    Mesenchymal KITL loss within PSCs accompanies pancreatic tumorigenesis. A, Uniform manifold approximation and projection (UMAP) visualization of expression of the indicated genes in normal PSCs and PSC-derived CAFs from scRNA-seq data ( n = 2 replicates pooled from n = 5 mice per arm). B, UMAP visualization of Il6 , Il33 , Col1a1 , and Col1a2 gene expression from normal PSCs and PSC-derived CAFs scRNA-seq dataset ( n = 2 replicates pooled from n = 5 mice per arm). C, UMAP visualization of Kitl transcript expression in normal PSCs and PSC-derived CAFs scRNA-seq dataset ( n = 2 replicates pooled from n = 5 mice per arm). D, Left, UMAP illustrating the cellular landscape of normal pancreatic (blue) and PDAC (red) mesenchymal cells, comprising 5,337 normal and 2,861 tumor cells. Harmony was used to integrate the datasets and correct for batch effects. Right, Monocle 3 trajectory analysis was used to depict expression of the Kitl gene along the inferred pseudotime trajectory. Cells are colored based on Kitl expression levels, with values ranging from low (black) to high (yellow), revealing the spatial and temporal expression patterns of Kitl ( n = 2 replicates pooled from n = 5 mice per arm). E, Left, qRT-PCR analysis of Kitl in quiescent (day 0) and culture-activated (day 7, on plastic) primary PSCs. Right, <t>Quantikine</t> <t>ELISA</t> KITL measurement of supernatant collected from primary PSCs in preactivated (day 2) and activated (day 10) states after 48 hours of incubation with media change on day 8 to harvest for day 10 sample. Immortalized ImPSC-1 included as the reference point. Data represents biological triplicate. F, qRT-PCR analysis of Kitl and Pdgfr α in indicated cell populations. Data show representative technical triplicates. G, Representative brightfield images of primary human PSCs and other mesenchyme. Scale bar, 50 μm. H, qRT-PCR analysis of indicated genes in primary human PSCs and other mesenchyme, shown for three independent patient samples. I, qRT-PCR analysis of Kitl in quiescent (day 0) and conditioned media–activated (day 14) primary human PSCs. Data represent biological triplicate. J, Representative images (left) and quantification (right) of RNA FISH staining for Fabp4 (green) and Kitl (red) in murine normal pancreas ( n = 3). Scale bar, 10 μm. Below, Representative RNAscope staining of GFP (green) protein and Kitl (red) mRNA in PDAC from the genetically engineered mouse model (GEMM) depicted in ( n = 3). Scale bar, 10 μm. K, Representative images and quantification of RNA FISH staining for VIM (green) and KITL (red) in human PDAC tissues between benign adjacent and PDAC regions ( n = 3). Scale bar, 20 μm. L, Representative images and quantification of RNAscope staining for Kitl (red) mRNA expression, GFP (green), and CD31 (magenta) in murine normal pancreas from Rosa26 mTmG/+ ;Fabp4-Cre mice ( n = 3). Scale bar, 20 μm. M, Representative images and quantification of RNAscope staining for GFP (green) protein and Kitl (red) mRNA in GEMM low-grade PanIN ( n = 3). Scale bar, 20 μm. N, Representative image of IHC staining for phospho-c-Kit (Y721, red) in normal murine pancreas ( n = 3). Scale bar, 10 μm. O, Representative images of IHC staining for vimentin (VIM, green) and Phospho-c-Kit (Y703, red) in benign adjacent and human PDAC tissues ( n = 3) Scale bar, 10 μm. For image quantification, at least four fields per tissue were analyzed and averaged. An unpaired t test was performed for comparisons between two groups. For comparisons more than two groups, significance was determined by the ordinary one-way ANOVA. Data are represented as mean ± SEM;*, P < 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001; Benign Adj., benign adjacent; CM, conditioned media; ns, not significant; other mes., other mesenchyme.
    Mouse Scf Quantifikine Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/scf+elisa+kit/Mouse+SCF+Quantikine+ELISA+Kit/10__1158_slash_2159___8290__cd___24___1079-344-24-29
    Average 93 stars, based on 1 article reviews
    mouse scf quantifikine elisa kit - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    90
    Thermo Fisher rat scf elisa kit
    Mesenchymal KITL loss within PSCs accompanies pancreatic tumorigenesis. A, Uniform manifold approximation and projection (UMAP) visualization of expression of the indicated genes in normal PSCs and PSC-derived CAFs from scRNA-seq data ( n = 2 replicates pooled from n = 5 mice per arm). B, UMAP visualization of Il6 , Il33 , Col1a1 , and Col1a2 gene expression from normal PSCs and PSC-derived CAFs scRNA-seq dataset ( n = 2 replicates pooled from n = 5 mice per arm). C, UMAP visualization of Kitl transcript expression in normal PSCs and PSC-derived CAFs scRNA-seq dataset ( n = 2 replicates pooled from n = 5 mice per arm). D, Left, UMAP illustrating the cellular landscape of normal pancreatic (blue) and PDAC (red) mesenchymal cells, comprising 5,337 normal and 2,861 tumor cells. Harmony was used to integrate the datasets and correct for batch effects. Right, Monocle 3 trajectory analysis was used to depict expression of the Kitl gene along the inferred pseudotime trajectory. Cells are colored based on Kitl expression levels, with values ranging from low (black) to high (yellow), revealing the spatial and temporal expression patterns of Kitl ( n = 2 replicates pooled from n = 5 mice per arm). E, Left, qRT-PCR analysis of Kitl in quiescent (day 0) and culture-activated (day 7, on plastic) primary PSCs. Right, <t>Quantikine</t> <t>ELISA</t> KITL measurement of supernatant collected from primary PSCs in preactivated (day 2) and activated (day 10) states after 48 hours of incubation with media change on day 8 to harvest for day 10 sample. Immortalized ImPSC-1 included as the reference point. Data represents biological triplicate. F, qRT-PCR analysis of Kitl and Pdgfr α in indicated cell populations. Data show representative technical triplicates. G, Representative brightfield images of primary human PSCs and other mesenchyme. Scale bar, 50 μm. H, qRT-PCR analysis of indicated genes in primary human PSCs and other mesenchyme, shown for three independent patient samples. I, qRT-PCR analysis of Kitl in quiescent (day 0) and conditioned media–activated (day 14) primary human PSCs. Data represent biological triplicate. J, Representative images (left) and quantification (right) of RNA FISH staining for Fabp4 (green) and Kitl (red) in murine normal pancreas ( n = 3). Scale bar, 10 μm. Below, Representative RNAscope staining of GFP (green) protein and Kitl (red) mRNA in PDAC from the genetically engineered mouse model (GEMM) depicted in ( n = 3). Scale bar, 10 μm. K, Representative images and quantification of RNA FISH staining for VIM (green) and KITL (red) in human PDAC tissues between benign adjacent and PDAC regions ( n = 3). Scale bar, 20 μm. L, Representative images and quantification of RNAscope staining for Kitl (red) mRNA expression, GFP (green), and CD31 (magenta) in murine normal pancreas from Rosa26 mTmG/+ ;Fabp4-Cre mice ( n = 3). Scale bar, 20 μm. M, Representative images and quantification of RNAscope staining for GFP (green) protein and Kitl (red) mRNA in GEMM low-grade PanIN ( n = 3). Scale bar, 20 μm. N, Representative image of IHC staining for phospho-c-Kit (Y721, red) in normal murine pancreas ( n = 3). Scale bar, 10 μm. O, Representative images of IHC staining for vimentin (VIM, green) and Phospho-c-Kit (Y703, red) in benign adjacent and human PDAC tissues ( n = 3) Scale bar, 10 μm. For image quantification, at least four fields per tissue were analyzed and averaged. An unpaired t test was performed for comparisons between two groups. For comparisons more than two groups, significance was determined by the ordinary one-way ANOVA. Data are represented as mean ± SEM;*, P < 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001; Benign Adj., benign adjacent; CM, conditioned media; ns, not significant; other mes., other mesenchyme.
    Rat Scf Elisa Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/scf+elisa+kit/pm39662467-306-50-54
    Average 90 stars, based on 1 article reviews
    rat scf elisa kit - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results


    HCC cells promote MC migration and sustain MC proliferation. (A, B) Timer3.0 database analysis of SCF expression in tumors and correlation analysis between SCF and MCs; (C) ELISA detection of SCF levels in tumor tissues and adjacent tissues; (D) Correlation analysis between TAMC density and SCF concentration in HCC tumor tissues; (E): Flow cytometry identification of expanded hMCs at week 4; (F, G) Transwell assay for hMC migration capacity; (H, I) Flow cytometry for hMC proliferation; (J, K) Flow cytometry for hMC cell cycle. Data are presented as mean ± SD. Figure (B) used independent samples t ‐tests ( n = 59). (D) Spearman 's rank correlation analysis ( n = 59); (G/I/K), one‐way ANOVA with Tukey's post‐hoc multiple comparison test ( N = 3). * indicates p < 0.05; *** indicates p < 0.001.

    Journal: Journal of Biochemical and Molecular Toxicology

    Article Title: Tumor‐Associated Mast Cells Drive Immunosuppression and Resistance to Anti‐PD‐1 Therapy in Hepatocellular Carcinoma Through CCL17/CCR4‐mediated Regulatory T‐Cell Recruitment

    doi: 10.1002/jbt.71127

    Figure Lengend Snippet: HCC cells promote MC migration and sustain MC proliferation. (A, B) Timer3.0 database analysis of SCF expression in tumors and correlation analysis between SCF and MCs; (C) ELISA detection of SCF levels in tumor tissues and adjacent tissues; (D) Correlation analysis between TAMC density and SCF concentration in HCC tumor tissues; (E): Flow cytometry identification of expanded hMCs at week 4; (F, G) Transwell assay for hMC migration capacity; (H, I) Flow cytometry for hMC proliferation; (J, K) Flow cytometry for hMC cell cycle. Data are presented as mean ± SD. Figure (B) used independent samples t ‐tests ( n = 59). (D) Spearman 's rank correlation analysis ( n = 59); (G/I/K), one‐way ANOVA with Tukey's post‐hoc multiple comparison test ( N = 3). * indicates p < 0.05; *** indicates p < 0.001.

    Article Snippet: The following kits were utilized: human SCF ELISA Kit (E‐EL‐H1299, Elabscience), human CCL1 ELISA kit (ab314600, Abcam), human CCL5 ELISA kit (ab174446, Abcam), human CCL17 ELISA kit (ab183366, Abcam), Human CCL22 ELISA Kit (ab242931, Abcam), Human CCL28 ELISA Kit (ab99988, Abcam), Human Granzyme B ELISA Kit (E‐EL‐H1617, Elabscience), Human Interferon‐γ (IFN‐γ) ELISA Kit (E‐EL‐H0108, Elabscience), Human TNF‐α ELISA Kit (E‐EL‐H0109, Elabscience), Human Perforin 1 ELISA Kit (E‐EL‐H1123, Elabscience), Mouse Granzyme B ELISA Kit (E‐EL‐M0594, Elabscience), Mouse IFN‐γ ELISA Kit (E‐EL‐M0048, Elabscience), Mouse TNF‐α ELISA Kit (E‐EL‐M3063, Elabscience), and Mouse Perforin ELISA Kit (E‐EL‐M0890, Elabscience).

    Techniques: Migration, Analysis, Expressing, Enzyme-linked Immunosorbent Assay, Concentration Assay, Flow Cytometry, Transwell Assay, Comparison, X-Ray Photoelectron Spectroscopy

    TAMCs recruit Tregs into the tumor microenvironment by secreting chemokines. (A) ELISA detection of CCL1, CCL5, CCL17, CCL22, and CCL28 secretion by TAMCs (after subtracting CCL1, CCL5, CCL17, CCL22, and CCL28 levels in TCCS); (B) ELISA detection of CCL17 levels in tumor tissues and adjacent tissues; (C) Correlation analysis between TAMCs and CCL17 concentration; D: Correlation analysis between Tregs and CCL17 concentration; (E, F) Transwell migration assay to assess Treg migration capacity. Data are presented as mean ± SD. (A, B), independent samples t ‐tests ( N = 3); (C, D) Spearman 's rank correlation analysis ( n = 59); (F), one‐way ANOVA and Tukey's multiple comparison test ( N = 3). * indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001.

    Journal: Journal of Biochemical and Molecular Toxicology

    Article Title: Tumor‐Associated Mast Cells Drive Immunosuppression and Resistance to Anti‐PD‐1 Therapy in Hepatocellular Carcinoma Through CCL17/CCR4‐mediated Regulatory T‐Cell Recruitment

    doi: 10.1002/jbt.71127

    Figure Lengend Snippet: TAMCs recruit Tregs into the tumor microenvironment by secreting chemokines. (A) ELISA detection of CCL1, CCL5, CCL17, CCL22, and CCL28 secretion by TAMCs (after subtracting CCL1, CCL5, CCL17, CCL22, and CCL28 levels in TCCS); (B) ELISA detection of CCL17 levels in tumor tissues and adjacent tissues; (C) Correlation analysis between TAMCs and CCL17 concentration; D: Correlation analysis between Tregs and CCL17 concentration; (E, F) Transwell migration assay to assess Treg migration capacity. Data are presented as mean ± SD. (A, B), independent samples t ‐tests ( N = 3); (C, D) Spearman 's rank correlation analysis ( n = 59); (F), one‐way ANOVA and Tukey's multiple comparison test ( N = 3). * indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001.

    Article Snippet: The following kits were utilized: human SCF ELISA Kit (E‐EL‐H1299, Elabscience), human CCL1 ELISA kit (ab314600, Abcam), human CCL5 ELISA kit (ab174446, Abcam), human CCL17 ELISA kit (ab183366, Abcam), Human CCL22 ELISA Kit (ab242931, Abcam), Human CCL28 ELISA Kit (ab99988, Abcam), Human Granzyme B ELISA Kit (E‐EL‐H1617, Elabscience), Human Interferon‐γ (IFN‐γ) ELISA Kit (E‐EL‐H0108, Elabscience), Human TNF‐α ELISA Kit (E‐EL‐H0109, Elabscience), Human Perforin 1 ELISA Kit (E‐EL‐H1123, Elabscience), Mouse Granzyme B ELISA Kit (E‐EL‐M0594, Elabscience), Mouse IFN‐γ ELISA Kit (E‐EL‐M0048, Elabscience), Mouse TNF‐α ELISA Kit (E‐EL‐M3063, Elabscience), and Mouse Perforin ELISA Kit (E‐EL‐M0890, Elabscience).

    Techniques: Enzyme-linked Immunosorbent Assay, Analysis, Concentration Assay, Transwell Migration Assay, Migration, Comparison

    The TAMCs‐Tregs axis inhibits CD8 + T cell function. (A, B) Flow cytometry analysis of Treg‐mediated suppression of CD8 + T cell proliferation; (C–F) ELISA for Granzyme B, IFN‐γ, TNF‐α, and Perforin in supernatants from CD8 + T cell proliferation assays. Data are presented as mean ± SD. One‐way ANOVA was performed, followed by Tukey's multiple comparison test for post‐hoc analysis ( N = 3). * indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001.

    Journal: Journal of Biochemical and Molecular Toxicology

    Article Title: Tumor‐Associated Mast Cells Drive Immunosuppression and Resistance to Anti‐PD‐1 Therapy in Hepatocellular Carcinoma Through CCL17/CCR4‐mediated Regulatory T‐Cell Recruitment

    doi: 10.1002/jbt.71127

    Figure Lengend Snippet: The TAMCs‐Tregs axis inhibits CD8 + T cell function. (A, B) Flow cytometry analysis of Treg‐mediated suppression of CD8 + T cell proliferation; (C–F) ELISA for Granzyme B, IFN‐γ, TNF‐α, and Perforin in supernatants from CD8 + T cell proliferation assays. Data are presented as mean ± SD. One‐way ANOVA was performed, followed by Tukey's multiple comparison test for post‐hoc analysis ( N = 3). * indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001.

    Article Snippet: The following kits were utilized: human SCF ELISA Kit (E‐EL‐H1299, Elabscience), human CCL1 ELISA kit (ab314600, Abcam), human CCL5 ELISA kit (ab174446, Abcam), human CCL17 ELISA kit (ab183366, Abcam), Human CCL22 ELISA Kit (ab242931, Abcam), Human CCL28 ELISA Kit (ab99988, Abcam), Human Granzyme B ELISA Kit (E‐EL‐H1617, Elabscience), Human Interferon‐γ (IFN‐γ) ELISA Kit (E‐EL‐H0108, Elabscience), Human TNF‐α ELISA Kit (E‐EL‐H0109, Elabscience), Human Perforin 1 ELISA Kit (E‐EL‐H1123, Elabscience), Mouse Granzyme B ELISA Kit (E‐EL‐M0594, Elabscience), Mouse IFN‐γ ELISA Kit (E‐EL‐M0048, Elabscience), Mouse TNF‐α ELISA Kit (E‐EL‐M3063, Elabscience), and Mouse Perforin ELISA Kit (E‐EL‐M0890, Elabscience).

    Techniques: Cell Function Assay, Flow Cytometry, Analysis, Enzyme-linked Immunosorbent Assay, Comparison

    Combination therapy of anti‐PD‐1 antibody and CCR4 antagonists reshapes the tumor immune microenvironment in HCC. (A–F) Flow cytometry analysis of immune cell proportions (MCs, Tregs, CD8 + T cells) in tumor tissue; G–K: ELISA detection of Granzyme B, IFN‐γ, TNF‐α, Perforin, and CCL17 levels. Data are presented as mean ± SD. One‐way ANOVA was performed, followed by Tukey's multiple comparison test for post‐hoc analysis ( n = 6). * indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001.

    Journal: Journal of Biochemical and Molecular Toxicology

    Article Title: Tumor‐Associated Mast Cells Drive Immunosuppression and Resistance to Anti‐PD‐1 Therapy in Hepatocellular Carcinoma Through CCL17/CCR4‐mediated Regulatory T‐Cell Recruitment

    doi: 10.1002/jbt.71127

    Figure Lengend Snippet: Combination therapy of anti‐PD‐1 antibody and CCR4 antagonists reshapes the tumor immune microenvironment in HCC. (A–F) Flow cytometry analysis of immune cell proportions (MCs, Tregs, CD8 + T cells) in tumor tissue; G–K: ELISA detection of Granzyme B, IFN‐γ, TNF‐α, Perforin, and CCL17 levels. Data are presented as mean ± SD. One‐way ANOVA was performed, followed by Tukey's multiple comparison test for post‐hoc analysis ( n = 6). * indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001.

    Article Snippet: The following kits were utilized: human SCF ELISA Kit (E‐EL‐H1299, Elabscience), human CCL1 ELISA kit (ab314600, Abcam), human CCL5 ELISA kit (ab174446, Abcam), human CCL17 ELISA kit (ab183366, Abcam), Human CCL22 ELISA Kit (ab242931, Abcam), Human CCL28 ELISA Kit (ab99988, Abcam), Human Granzyme B ELISA Kit (E‐EL‐H1617, Elabscience), Human Interferon‐γ (IFN‐γ) ELISA Kit (E‐EL‐H0108, Elabscience), Human TNF‐α ELISA Kit (E‐EL‐H0109, Elabscience), Human Perforin 1 ELISA Kit (E‐EL‐H1123, Elabscience), Mouse Granzyme B ELISA Kit (E‐EL‐M0594, Elabscience), Mouse IFN‐γ ELISA Kit (E‐EL‐M0048, Elabscience), Mouse TNF‐α ELISA Kit (E‐EL‐M3063, Elabscience), and Mouse Perforin ELISA Kit (E‐EL‐M0890, Elabscience).

    Techniques: Flow Cytometry, Analysis, Immune Cell, Tissue, Enzyme-linked Immunosorbent Assay, Comparison

    Validation of the synergistic antitumor efficacy of the triple‐drug therapy in an in situ Hepa1‐6 HCC model. (A) Representative images of in situ tumors; (B): Tumor volume in each group; (C) Tumor weight in each group; (D) Average ratio of liver weight to body weight; (E, F): Ki67 immunohistochemical staining and quantitative analysis; (G–L) Flow cytometry detection of the proportions of various immune cells (mast cells, Tregs, CD8 + T cells); (M) ELISA detection of Granzyme B, IFN‐γ, TNF‐α, and perforin levels. Data are presented as mean ± SD. One‐way ANOVA was performed, followed by Tukey's multiple comparison test for post‐hoc analysis ( n = 6).

    Journal: Journal of Biochemical and Molecular Toxicology

    Article Title: Tumor‐Associated Mast Cells Drive Immunosuppression and Resistance to Anti‐PD‐1 Therapy in Hepatocellular Carcinoma Through CCL17/CCR4‐mediated Regulatory T‐Cell Recruitment

    doi: 10.1002/jbt.71127

    Figure Lengend Snippet: Validation of the synergistic antitumor efficacy of the triple‐drug therapy in an in situ Hepa1‐6 HCC model. (A) Representative images of in situ tumors; (B): Tumor volume in each group; (C) Tumor weight in each group; (D) Average ratio of liver weight to body weight; (E, F): Ki67 immunohistochemical staining and quantitative analysis; (G–L) Flow cytometry detection of the proportions of various immune cells (mast cells, Tregs, CD8 + T cells); (M) ELISA detection of Granzyme B, IFN‐γ, TNF‐α, and perforin levels. Data are presented as mean ± SD. One‐way ANOVA was performed, followed by Tukey's multiple comparison test for post‐hoc analysis ( n = 6).

    Article Snippet: The following kits were utilized: human SCF ELISA Kit (E‐EL‐H1299, Elabscience), human CCL1 ELISA kit (ab314600, Abcam), human CCL5 ELISA kit (ab174446, Abcam), human CCL17 ELISA kit (ab183366, Abcam), Human CCL22 ELISA Kit (ab242931, Abcam), Human CCL28 ELISA Kit (ab99988, Abcam), Human Granzyme B ELISA Kit (E‐EL‐H1617, Elabscience), Human Interferon‐γ (IFN‐γ) ELISA Kit (E‐EL‐H0108, Elabscience), Human TNF‐α ELISA Kit (E‐EL‐H0109, Elabscience), Human Perforin 1 ELISA Kit (E‐EL‐H1123, Elabscience), Mouse Granzyme B ELISA Kit (E‐EL‐M0594, Elabscience), Mouse IFN‐γ ELISA Kit (E‐EL‐M0048, Elabscience), Mouse TNF‐α ELISA Kit (E‐EL‐M3063, Elabscience), and Mouse Perforin ELISA Kit (E‐EL‐M0890, Elabscience).

    Techniques: Biomarker Discovery, In Situ, Immunohistochemical staining, Staining, Analysis, Flow Cytometry, Enzyme-linked Immunosorbent Assay, Comparison

    Mesenchymal KITL loss within PSCs accompanies pancreatic tumorigenesis. A, Uniform manifold approximation and projection (UMAP) visualization of expression of the indicated genes in normal PSCs and PSC-derived CAFs from scRNA-seq data ( n = 2 replicates pooled from n = 5 mice per arm). B, UMAP visualization of Il6 , Il33 , Col1a1 , and Col1a2 gene expression from normal PSCs and PSC-derived CAFs scRNA-seq dataset ( n = 2 replicates pooled from n = 5 mice per arm). C, UMAP visualization of Kitl transcript expression in normal PSCs and PSC-derived CAFs scRNA-seq dataset ( n = 2 replicates pooled from n = 5 mice per arm). D, Left, UMAP illustrating the cellular landscape of normal pancreatic (blue) and PDAC (red) mesenchymal cells, comprising 5,337 normal and 2,861 tumor cells. Harmony was used to integrate the datasets and correct for batch effects. Right, Monocle 3 trajectory analysis was used to depict expression of the Kitl gene along the inferred pseudotime trajectory. Cells are colored based on Kitl expression levels, with values ranging from low (black) to high (yellow), revealing the spatial and temporal expression patterns of Kitl ( n = 2 replicates pooled from n = 5 mice per arm). E, Left, qRT-PCR analysis of Kitl in quiescent (day 0) and culture-activated (day 7, on plastic) primary PSCs. Right, Quantikine ELISA KITL measurement of supernatant collected from primary PSCs in preactivated (day 2) and activated (day 10) states after 48 hours of incubation with media change on day 8 to harvest for day 10 sample. Immortalized ImPSC-1 included as the reference point. Data represents biological triplicate. F, qRT-PCR analysis of Kitl and Pdgfr α in indicated cell populations. Data show representative technical triplicates. G, Representative brightfield images of primary human PSCs and other mesenchyme. Scale bar, 50 μm. H, qRT-PCR analysis of indicated genes in primary human PSCs and other mesenchyme, shown for three independent patient samples. I, qRT-PCR analysis of Kitl in quiescent (day 0) and conditioned media–activated (day 14) primary human PSCs. Data represent biological triplicate. J, Representative images (left) and quantification (right) of RNA FISH staining for Fabp4 (green) and Kitl (red) in murine normal pancreas ( n = 3). Scale bar, 10 μm. Below, Representative RNAscope staining of GFP (green) protein and Kitl (red) mRNA in PDAC from the genetically engineered mouse model (GEMM) depicted in ( n = 3). Scale bar, 10 μm. K, Representative images and quantification of RNA FISH staining for VIM (green) and KITL (red) in human PDAC tissues between benign adjacent and PDAC regions ( n = 3). Scale bar, 20 μm. L, Representative images and quantification of RNAscope staining for Kitl (red) mRNA expression, GFP (green), and CD31 (magenta) in murine normal pancreas from Rosa26 mTmG/+ ;Fabp4-Cre mice ( n = 3). Scale bar, 20 μm. M, Representative images and quantification of RNAscope staining for GFP (green) protein and Kitl (red) mRNA in GEMM low-grade PanIN ( n = 3). Scale bar, 20 μm. N, Representative image of IHC staining for phospho-c-Kit (Y721, red) in normal murine pancreas ( n = 3). Scale bar, 10 μm. O, Representative images of IHC staining for vimentin (VIM, green) and Phospho-c-Kit (Y703, red) in benign adjacent and human PDAC tissues ( n = 3) Scale bar, 10 μm. For image quantification, at least four fields per tissue were analyzed and averaged. An unpaired t test was performed for comparisons between two groups. For comparisons more than two groups, significance was determined by the ordinary one-way ANOVA. Data are represented as mean ± SEM;*, P < 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001; Benign Adj., benign adjacent; CM, conditioned media; ns, not significant; other mes., other mesenchyme.

    Journal: Cancer Discovery

    Article Title: Stromal KITL/SCF Maintains Pancreas Tissue Homeostasis and Restrains Tumor Progression

    doi: 10.1158/2159-8290.CD-24-1079

    Figure Lengend Snippet: Mesenchymal KITL loss within PSCs accompanies pancreatic tumorigenesis. A, Uniform manifold approximation and projection (UMAP) visualization of expression of the indicated genes in normal PSCs and PSC-derived CAFs from scRNA-seq data ( n = 2 replicates pooled from n = 5 mice per arm). B, UMAP visualization of Il6 , Il33 , Col1a1 , and Col1a2 gene expression from normal PSCs and PSC-derived CAFs scRNA-seq dataset ( n = 2 replicates pooled from n = 5 mice per arm). C, UMAP visualization of Kitl transcript expression in normal PSCs and PSC-derived CAFs scRNA-seq dataset ( n = 2 replicates pooled from n = 5 mice per arm). D, Left, UMAP illustrating the cellular landscape of normal pancreatic (blue) and PDAC (red) mesenchymal cells, comprising 5,337 normal and 2,861 tumor cells. Harmony was used to integrate the datasets and correct for batch effects. Right, Monocle 3 trajectory analysis was used to depict expression of the Kitl gene along the inferred pseudotime trajectory. Cells are colored based on Kitl expression levels, with values ranging from low (black) to high (yellow), revealing the spatial and temporal expression patterns of Kitl ( n = 2 replicates pooled from n = 5 mice per arm). E, Left, qRT-PCR analysis of Kitl in quiescent (day 0) and culture-activated (day 7, on plastic) primary PSCs. Right, Quantikine ELISA KITL measurement of supernatant collected from primary PSCs in preactivated (day 2) and activated (day 10) states after 48 hours of incubation with media change on day 8 to harvest for day 10 sample. Immortalized ImPSC-1 included as the reference point. Data represents biological triplicate. F, qRT-PCR analysis of Kitl and Pdgfr α in indicated cell populations. Data show representative technical triplicates. G, Representative brightfield images of primary human PSCs and other mesenchyme. Scale bar, 50 μm. H, qRT-PCR analysis of indicated genes in primary human PSCs and other mesenchyme, shown for three independent patient samples. I, qRT-PCR analysis of Kitl in quiescent (day 0) and conditioned media–activated (day 14) primary human PSCs. Data represent biological triplicate. J, Representative images (left) and quantification (right) of RNA FISH staining for Fabp4 (green) and Kitl (red) in murine normal pancreas ( n = 3). Scale bar, 10 μm. Below, Representative RNAscope staining of GFP (green) protein and Kitl (red) mRNA in PDAC from the genetically engineered mouse model (GEMM) depicted in ( n = 3). Scale bar, 10 μm. K, Representative images and quantification of RNA FISH staining for VIM (green) and KITL (red) in human PDAC tissues between benign adjacent and PDAC regions ( n = 3). Scale bar, 20 μm. L, Representative images and quantification of RNAscope staining for Kitl (red) mRNA expression, GFP (green), and CD31 (magenta) in murine normal pancreas from Rosa26 mTmG/+ ;Fabp4-Cre mice ( n = 3). Scale bar, 20 μm. M, Representative images and quantification of RNAscope staining for GFP (green) protein and Kitl (red) mRNA in GEMM low-grade PanIN ( n = 3). Scale bar, 20 μm. N, Representative image of IHC staining for phospho-c-Kit (Y721, red) in normal murine pancreas ( n = 3). Scale bar, 10 μm. O, Representative images of IHC staining for vimentin (VIM, green) and Phospho-c-Kit (Y703, red) in benign adjacent and human PDAC tissues ( n = 3) Scale bar, 10 μm. For image quantification, at least four fields per tissue were analyzed and averaged. An unpaired t test was performed for comparisons between two groups. For comparisons more than two groups, significance was determined by the ordinary one-way ANOVA. Data are represented as mean ± SEM;*, P < 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001; Benign Adj., benign adjacent; CM, conditioned media; ns, not significant; other mes., other mesenchyme.

    Article Snippet: Concentrated supernatants were quantified using the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, 23225), and mouse KITL protein quantification was performed using the Mouse SCF Quantikine ELISA Kit (R&D Systems, MCK00) according to the manufacturer’s protocol.

    Techniques: Expressing, Derivative Assay, Gene Expression, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay, Incubation, Staining, RNAscope, Immunohistochemistry